Yahoo Finance Results
- InvestorPlace via Yahoo FinanceNov 27 16:22 PM
There are even biotech stocks that offer you some big yields as well. Even better, is that while these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left ...
- Market Watch1 day ago
- ABC News21 hours ago
Global Human Microbiome Modulators Market: Focus on Non-Dairy Supplements, Drugs, Applications, 15 Countries Data, Pipeline Product Mapping...Market Watch5 hours ago
- Motley Fool via Yahoo FinanceNov 24 12:33 PM
GW's market cap is more than 10 times larger than Corbus' market cap. You don't have to look hard to find a big reason to like GW Pharmaceuticals.
- GOBankingRates via Yahoo FinanceDec 03 20:00 PM
Berkshire shed 2.3 million shares from its American Airlines position, bringing it to 43.7 million shares, and sold about 2.2 million shares of United Continental Holdings to give him just under ...
- Fortune via Yahoo FinanceDec 10 14:44 PM
Statement from Sanofi, maker of Ambien, in response to Roseanne Barr’s claim that she took the drug before firing off offensive tweets.
News about Sanofi-Aventis S.A., including commentary and archival articles published in The New York Times.
Sanofi is a leader in the global pharmaceutical market, with an extensive line of prescription medicines. Addressing fundamental health issues, Sanofi US strives to make major therapeutic solutions available for patients.
Sanofi has determined that its activities are compliant with applicable law. In light of the nature of the activities concerned, Sanofi and its affiliates intend to continue their activities in Iran."--Sanofi S.A. has a U.S. Website--Sanofi Pasteur and Sanofi U.S. Services inc are subsidiaries of Saofi S.A.--
Sanofi S.A.'s dengue vaccine, Dengvaxia, has been recommended for approval in Europe by the European Medicines Agency's Committee for Medicinal Products for Human Use, the company said early Friday.
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world’s fifth-largest by prescription sales. The company was formed as Sanofi-Aventis in 2004 by the merger of Aventis and Sanofi-Synthélabo, which were each the product of several previous mergers.
Sanofi S.A. is one of the worldwide leaders in the pharmaceutical industry. The French multinational pharmaceutical company is headquartered in Paris and is the world's fourth largest prescription drug manufacturer. Ongoing research and development drives company success across its many subsidiaries. With more than